Parathyroidectomy Underused for Primary Hyperparathyroidism

A large national cohort study has uncovered a striking gap in the treatment of primary hyperparathyroidism (PHPT): despite clear guideline recommendations, parathyroidectomy—the surgical removal of overactive parathyroid glands—is vastly underused in patients with end-organ damage. Além disso, published in JAMA Surgery, the research by Seib et al. analyzed data from over 43,000 adults and found that only 19.9% of those with end-organ damage underwent surgery. Portanto, the findings raise important questions about adherence to clinical guidelines and optimal management of this common endocrine disorder.

Primary hyperparathyroidism occurs when one or more parathyroid glands become overactive, leading to excessive calcium in the blood. Consequentemente, over time, this can cause complications such as brittle bones, kidney stones, and impaired kidney function—collectively termed end-organ damage. Contudo, current guidelines recommend parathyroidectomy for patients who exhibit such damage, yet the real-world application appears far from universal.

Key Findings from a National Cohort

The study examined 43,481 patients with biochemically confirmed primary hyperparathyroidism. Além disso, at diagnosis, 51.3% already showed evidence of end-organ damage, which includes complications like kidney stones, osteoporosis, or reduced kidney function. Em seguida, among those with damage, the median time from diagnosis to surgery was 208 days, yet only 19.9% ultimately had parathyroidectomy during follow-up. Por outro lado, for patients without end-organ damage initially, the situation was also concerning: 32% developed new signs of organ damage over time, and among these, only 19.9% underwent surgery, with a median delay of 154 days after damage detection. Portanto, these numbers highlight a significant underutilization of a potentially curative intervention. No entanto, while the statistics reveal low surgery rates, the baseline characteristics of the patients offer additional insight.

Patient Profiles and Risk Factors

The cohort had a mean serum calcium level of 10.5 mg/dL and a mean parathyroid hormone (PTH) level of 115.3 pg/mL at diagnosis. Ademais, patients with end-organ damage tended to be older and had higher PTH levels, while serum calcium levels did not differ significantly between those with and without damage. Além disso, interestingly, severe hypercalcemia—defined as levels above 11.2 mg/dL—was associated with an increased risk of developing end-organ damage within the first year after diagnosis, though that risk diminished over time. Consequentemente, this suggests that early aggressive monitoring may be warranted for patients with markedly elevated calcium. Contudo, however, the decision to recommend surgery is not always straightforward, as the evidence on its benefits is mixed.

Weighing the Evidence: Benefits and Controversies

Guidelines endorse parathyroidectomy for PHPT patients with end-organ damage, but real-world data complicate the picture. Por exemplo, one retrospective cohort study found that surgery was linked to a 24% to 63% reduction in fracture risk over a 10-year period, depending on the fracture type—a compelling argument for intervention. No entanto, on the other hand, an observational study involving veterans detected no long-term kidney function benefit from parathyroidectomy, raising doubts about its renal protective effects. Portanto, the divergent findings underscore the need for individualized decision-making and further research.

Understanding the Study’s Limitations

Beyond the clinical outcomes, the study’s methodology also warrants careful interpretation. Em resumo, the authors acknowledged that the study was limited by its observational design, which cannot establish causality. Ademais, additionally, including chronic kidney disease (CKD) as an outcome may have overestimated the kidney-related morbidity attributable to PHPT, since CKD can arise from many other causes. Dessa forma, these caveats mean that while the low surgery rates are clear, the reasons behind them—and the exact impact on patient health—require more rigorous investigation.

Closing the Treatment Gap

Despite these limitations, the findings emphasize the need to bridge the gap between guidelines and practice. Em resumo, the underuse of parathyroidectomy in PHPT with end-organ damage is a multifactorial problem. Por exemplo, it may stem from patient reluctance, lack of access to specialized surgeons, or insufficient awareness among clinicians. Consequentemente, for individuals diagnosed with primary hyperparathyroidism, especially those with signs of organ damage, a discussion with a healthcare professional about the potential benefits and risks of surgery is crucial. Sobretudo, while parathyroidectomy is not without risks, it remains the only definitive treatment for the disease. Assim sendo, as the evidence evolves, clearer protocols and better patient education could help ensure that those who stand to benefit most actually receive surgery. Portanto, the study serves as a call to action for both the medical community and patients to prioritize guideline-adherent management.

In the end, the research underscores that while surgery can offer substantial benefits—such as reduced fracture risk—it is not a one-size-fits-all solution. Além disso, the observational nature of the study and the mixed findings on kidney outcomes highlight the necessity for personalized care. Portanto, patients and physicians should weigh the available evidence, consider individual risk factors, and make informed decisions together.

Source

• www.medpagetoday.com
• JAMA Surgery (jamanetwork.com)
• guideline recommendations (academic.oup.com)
• accompanying commentary (jamanetwork.com)
• retrospective cohort study (www.acpjournals.org)
• comments powered by Disqus. (disqus.com)